Catalysts for Actemra
61 tracked
Apr 30, 2026
phase 1 completion
Chugai Pharmaceutical Co Ltd — tocilizumab (Phase I Trial Completion)
tocilizumab
→
Dec 10, 2025
approval
ACTEMRA (TOCILIZUMAB) — FDA approval
tocilizumab
→
Dec 10, 2025
approval
ACTEMRA (TOCILIZUMAB) — FDA approval
tocilizumab
→
Aug 8, 2025
approval
ACTEMRA (TOCILIZUMAB) — FDA approval
tocilizumab
→
Aug 8, 2025
approval
ACTEMRA (TOCILIZUMAB) — FDA approval
tocilizumab
→
Dec 10, 2024
approval
ACTEMRA (TOCILIZUMAB) — FDA approval
tocilizumab
→
Dec 10, 2024
approval
ACTEMRA (TOCILIZUMAB) — FDA approval
tocilizumab
→
Sep 20, 2024
approval
ACTEMRA (TOCILIZUMAB) — FDA approval
tocilizumab
→
Sep 20, 2024
approval
ACTEMRA (TOCILIZUMAB) — FDA approval
tocilizumab
→
Sep 19, 2024
approval
ACTEMRA (TOCILIZUMAB) — FDA approval
tocilizumab
→
Sep 19, 2024
approval
ACTEMRA (TOCILIZUMAB) — FDA approval
tocilizumab
→
Dec 21, 2022
approval
ACTEMRA (TOCILIZUMAB) — FDA approval
tocilizumab
→
Dec 21, 2022
approval
ACTEMRA (TOCILIZUMAB) — FDA approval
tocilizumab
→
Feb 28, 2022
approval
ACTEMRA (TOCILIZUMAB) — FDA approval
tocilizumab
→
Feb 28, 2022
approval
ACTEMRA (TOCILIZUMAB) — FDA approval
tocilizumab
→
Oct 22, 2021
approval
ACTEMRA (TOCILIZUMAB) — FDA approval
tocilizumab
→
Oct 22, 2021
approval
ACTEMRA (TOCILIZUMAB) — FDA approval
tocilizumab
→
Mar 4, 2021
approval
ACTEMRA (TOCILIZUMAB) — FDA approval
tocilizumab
→
Mar 4, 2021
approval
ACTEMRA (TOCILIZUMAB) — FDA approval
tocilizumab
→
May 28, 2020
approval
ACTEMRA (TOCILIZUMAB) — FDA approval
tocilizumab
→
May 28, 2020
approval
ACTEMRA (TOCILIZUMAB) — FDA approval
tocilizumab
→
Jun 11, 2019
approval
ACTEMRA (TOCILIZUMAB) — FDA approval
tocilizumab
→
Jun 11, 2019
approval
ACTEMRA (TOCILIZUMAB) — FDA approval
tocilizumab
→
Apr 11, 2019
approval
ACTEMRA (TOCILIZUMAB) — FDA approval
tocilizumab
→
Apr 11, 2019
approval
ACTEMRA (TOCILIZUMAB) — FDA approval
tocilizumab
→
Apr 11, 2019
approval
ACTEMRA (TOCILIZUMAB) — FDA approval
tocilizumab
→
Dec 20, 2018
approval
ACTEMRA (TOCILIZUMAB) — FDA approval
tocilizumab
→
Dec 20, 2018
approval
ACTEMRA (TOCILIZUMAB) — FDA approval
tocilizumab
→
Nov 19, 2018
approval
ACTEMRA (TOCILIZUMAB) — FDA approval
tocilizumab
→
Nov 19, 2018
approval
ACTEMRA (TOCILIZUMAB) — FDA approval
tocilizumab
→